Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marte

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Review for Medical and Pharmacological Sciences|February 18, 2022
The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control studyG La Torre, M Marte, A P Massetti, et al.
Journal of the International AIDS Society|October 24, 2024
Power, data and social accountability: defining a community-led monitoring model for strengthened health service deliveryNdivhuwo Rambau, Soeurette Policar, Alana R Sharp, et al.
Clinical Breast Cancer|September 28, 2019
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022Rachel A Freedman, Rebecca S Gelman, Nathalie Y R Agar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain MetastasesRachel A Freedman, Rebecca S Gelman, Carey K Anders, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Review for Medical and Pharmacological Sciences|February 18, 2022
The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control studyG La Torre, M Marte, A P Massetti, et al.
Journal of the International AIDS Society|October 24, 2024
Power, data and social accountability: defining a community-led monitoring model for strengthened health service deliveryNdivhuwo Rambau, Soeurette Policar, Alana R Sharp, et al.
Clinical Breast Cancer|September 28, 2019
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022Rachel A Freedman, Rebecca S Gelman, Nathalie Y R Agar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain MetastasesRachel A Freedman, Rebecca S Gelman, Carey K Anders, et al.
Pageof 3